So you have an R&D pilot plant that is being majority funded by Australian tax payers and a sales agreement with a Chinese company.
NTU current business plan is to produce a 52% mixed concentrate low value product and sell it into China, an already oversupplied market. Wheres the value add in that?
BTW NTU management are expecting the $10m off take prepayment to be made during March Quarter. I don’t believe it is going to happen, just like every other failed funding agreement with Chinese companies. Doubt any company is going Tom risk that sort of money on an unviable business plan.
Big dose of reality, page-64
-
- There are more pages in this discussion • 63 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NTU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
-0.002(9.09%) |
Mkt cap ! $135.9M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.2¢ | 2.0¢ | $48.07K | 2.306M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 6572864 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 700000 | 1 |
View Market Depth
| Last trade - 16.10pm 28/11/2024 (20 minute delay) ? |
| NTU (ASX) Chart |
